Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 7, 2009, Pages 3353-3359

  Dismuke, William M ^a   Sharif, Najam A ^b   Ellis, Dorette Z ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b Alcon Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 [[4 CARBOXYBUTYL[2 [(4 PHENETHYLBENZYL)OXY]PHENETHYL]AMINO]METHYL]BENZOIC ACID; 8 BROMO CYCLIC GMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; NITRIC OXIDE; 1H (1,2,4)OXADIAZOLO(4,3 A)QUINOXALIN 1 ONE; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; 3-(5'-HYDROXYMETHYL-2'-FURYL)-1-BENZYLINDAZOLE; 8-BROMOCYCLIC GMP; BENZOIC ACID DERIVATIVE; CALCEIN AM; DRUG DERIVATIVE; ENZYME ACTIVATOR; ENZYME INHIBITOR; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; GUANYLATE CYCLASE; INDAZOLE DERIVATIVE; OXADIAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE;

AQUEOUS HUMOR; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL LINE; CELL VOLUME; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; ADULT; AGED; CELL SIZE; CYTOLOGY; DRUG EFFECT; METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; BENZOIC ACIDS; CELL SIZE; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATORS; ENZYME INHIBITORS; FLUORESCEINS; FLUORESCENT DYES; GUANYLATE CYCLASE; HUMANS; INDAZOLES; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MICROSCOPY, CONFOCAL; NITRIC OXIDE; OXADIAZOLES; QUINOXALINES; TRABECULAR MESHWORK;

EID: 67649992691     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3127     Document Type: Article

References (41)

1. Garbers DL. Purification of soluble guanylate cyclase from rat lung. J Biol Chem. 1979;254:240-243.
2. Wedel B, Harteneck C, Foerster J, et al. Functional domains of soluble guanylyl cyclase. J Biol Chem. 1995;270:24871-24875.
3. Arnold WP, Mittal CK, Katsuki S, et al. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A. 1977;74:3203-3207.
4. Ca ion channel. Am J Physiol Cell Physiol. 2008;294:C1378-C1386.
5. Nathanson JA. Nitrovasodilators as a new class of ocular hypotensive agents. J Pharmacol Exp Ther. 1992;260:956-965.
6. Ko FN, Wu CC, Kuo SC, et al. YC-1, a novel activator of platelet guanylate cyclase. Blood. 1994;84:4226-4233.
7. Schmidt PM, Schramm M, Schroder H, et al. Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase. J Biol Chem. 2004;279:3025-3032.
8. Wiederholt M. Direct involvement of trabecular meshwork in the regulation of aqueous humor outflow. Curr Opin Ophthalmol. 1998;9:46-49.
9. Llobet A, Gual A, Pales J, et al. Bradykinin decreases outflow facility in perfused anterior segments and induces shape changes in passaged BTM cells in vitro. Invest Ophthalmol Vis Sci. 1999;40:113-125.
10. Wiederholt M, Thieme H, Stumpff F. The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res. 2000;19:271-295.
11. Rao PV, Deng PF, Kumar J, et al. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci. 2001;42:1029-1037.
12. Freddo TF, Patterson MM, Scott DR, et al. Influence of mercurial sulfhydryl agents on aqueous outflow pathways in enucleated eyes. Invest Ophthalmol VisSci. 1984;25:278-285.
13. O'Donnell ME, Brandt JD, Curry FR. Na-K-Cl cotransport regulates intracellular volume and monolayer permeability of trabecular meshwork cells. Am J Physiol. 1995;268:C1067-C1074.
14. Gual A, Llobet A, Gilabert R, et al. Effects of time of storage, albumin, and osmolality changes on outflow facility (C) of bovine anterior segment in vitro. Invest Ophthalmol Vis Sci. 1997;38: 2165-2171.
15. Al-Aswad LA, Gong H, Lee D, et al. Effects of Na-K-2Cl cotransport regulators on outflow facility in calf and human eyes in vitro. Invest Ophthalmol Vis Sci. 1999;40:1695-1701.
16. Srinivas SP, Maertens C, Goon LH, et al. Cell volume response to hyposmotic shock and elevated cAMP in bovine trabecular meshwork cells. Exp Eye Res. 2004;78:15-26.
17. Soto D, Comes N, Ferrer E, et al. Modulation of aqueous humor outflow by ionic mechanisms involved in trabecular meshwork cell volume regulation. Invest Ophthalmol Vis Sci. 2004;45:3650-3661.
18. Mitchell CH, Fleischhauer JC, Stamer WD, et al. Human trabecular meshwork cell volume regulation. Am J Physiol. 2002;283:C315-C326.
19. Ziyadeh FN, Mills JW, Kleinzeller A. Hypotonicity and cell volume regulation in shark rectal gland: role of organic osmolytes and F-actin. Am J Physiol. 1992;262:F468-F479.
20. Henson JH, Roesener CD, Gaetano CJ, et al. Confocal microscopic observation of cytoskeletal reorganizations in cultured shark rectal gland cells following treatment with hypotonic shock and high external K_. J Exp Zool. 1997;279:415-424.
21. Tian B, Geiger B, Epstein DL, et al. Cytoskeletal involvement in the regulation of aqueous humor outflow. Invest Ophthalmol Vis Sci. 2000;41:619-623.
22. Stamer WD, Seftor RE, Williams SK, et al. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14:611-617.
23. Stamer WD, Roberts BC, Howell DN, et al. Isolation, culture, and characterization of endothelial cells from Schlemm's canal. Invest Ophthalmol Vis Sci. 1998;39:1804-1812.
24. Comes N, Abad E, Morales M, et al. Identification and functional characterization of ClC-2 chloride channels in trabecular meshwork cells. Exp Eye Res. 2006;83:877-889.
25. Wu CC, Ko FN, Kuo SC, et al. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. BrJ Pharmacol. 1995;116:1973-1978.
26. Garthwaite J, Southam E, Boulton CL, et al. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-1. Mol Pharmacol. 1995;48: 184-188.
27. Stumpff F, Strauss O, Boxberger M, et al. Characterization of maxi-K-channels in bovine trabecular meshwork and their activation by cyclic guanosine monophosphate. Invest Ophthalmol Vis Sci. 1997;38:1883-1892.
28. Stasch JP, Schmidt P, Alonso-Alija C, et al. NO-and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol. 2002;136:773-783.
29. Acott TS, Kingsley PD, Samples JR, et al. Human trabecular meshwork organ culture: morphology and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci. 1988;29:90-100.
30. Krupin T, Civan MM. In: Ritch R, Shields MB, eds. The Glaucomas. St. Louis: Mosby; 1995:251-280.
31. Fuchshofer R, Welge-Lussen U, Lutjen-Drecoll E, et al. Biochemical and morphological analysis of basement membrane component expression in corneoscleral and cribriform human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2006;47:794-801.
32. Schmidt P, Schramm M, Schroder H, et al. Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase. Eur J Pharmacol. 2003;468:167-174.
33. Putney LK, Brandt JD, O'Donnell ME. Na-K-Cl cotransport in normal and glaucomatous human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1999;40:425-434.
34. Larsen AK, Jensen BS, Hoffmann EK. Activation of protein kinase C during cell volume regulation in Ehrlich mouse ascites tumor cells. Biochim Biophys Acta. 1994;1222:477-482.
35. Robertson BE, Schubert R, Hescheler J, et al. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol. 1993;265:C299-C303.
36. Alioua A, Tanaka Y, Wallner M, et al. The large conductance, voltage-dependent, and calcium-sensitive K_ channel, Hslo, is a target of cGMP-dependent protein kinase phosphorylation in vivo. J Biol Chem. 1998;273:32950-32956.
37. Okada Y, Maeno E, Shimizu T, et al. Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol. 2001;532:3-16.
38. Clemo HF, Baumgarten CM, Ellenbogen KA, et al. Atrial natriuretic peptide and cardiac electrophysiology: autonomic and direct effects. J Cardiovasc Electrophysiol. 1996;7:149-162.
39. Ellis DZ, Nathanson JA, Rabe J, et al. Carbachol and nitric oxide inhibition of Na,K-ATPase activity in bovine ciliary processes. Invest Ophthalmol Vis Sci. 2001;42:2625-2631.
40. Shahidullah M, Delamere NA. NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye. Br J Pharmacol. 2006;148:871-880.
41. Kotikoski H, Alajuuma P, Moilanen E, et al. Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J Ocul Pharmacol Ther. 2002;18:11-23.